✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Telix Pharmaceuticals Limited

Common Name
Telix Pharmaceuticals
Country
Australia
Sector
Healthcare
Industry
Biotechnology
Employees
1,120
Ticker
TLX
Exchange
Australian Securities Exchange
Description
Telix Pharmaceuticals Limited is a global, commercial-stage biopharmaceutical company specializing in the development and commercialization of targeted radiopharmaceuticals for oncology. Headquartered...

Telix Pharmaceuticals's Revenues Data

Explore Telix Pharmaceuticals's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
803,794,000a
516,551,000a
332,978,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Telix Pharmaceuticals’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Telix Pharmaceuticals's 20-F 2025